NDAQ vs TTRX · P/E 41, rev $2.53B vs $187.1M cap
Nasdaq Inc (NDAQ) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
TTRX does not have a complete income-statement cache yet.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the NDAQ and TTRX stock pages for the full models.
Not investment advice.